R&D Directions

Retinitis pigmentosa (RP)

Retinitis pigmentosa (RP) is a group of inherited eye disease characterized by the progressive dysfunction of predominantly retinal rod followed by cone photoreceptor cells. The rods and cone photoreceptor cells are responsible
for converting light to electrical impulses that are transmitted to the brain. RP is the most common subtype of retinal disease, with a frequency of 1 in 3000-7000 individuals, with over 1.5 million people affected worldwide. Currently, there are no treatment available to stop the disease progression and restore the vision. The treatment available for RP is vitamin A, which can only slow the progression of the disease. Therefore, the disease is considered as incurable and there is a high-unmet need to develop the treatment for RP.